Your browser doesn't support javascript.
loading
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
Gulla, Annamaria; Morelli, Eugenio; Samur, Mehmet K; Botta, Cirino; Hideshima, Teru; Bianchi, Giada; Fulciniti, Mariateresa; Malvestiti, Stefano; Prabhala, Rao H; Talluri, Srikanth; Wen, Kenneth; Tai, Yu-Tzu; Richardson, Paul G; Chauhan, Dharminder; Sewastianik, Tomasz; Carrasco, Ruben D; Munshi, Nikhil C; Anderson, Kenneth C.
Afiliação
  • Gulla A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. kenneth_anderson@dfci.harvard.edu annamaria_gulla@dfci.harvard.edu.
  • Morelli E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Samur MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Botta C; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hideshima T; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Bianchi G; Department of Oncohematology, "Annunziata" Hospital, Cosenza, Italy.
  • Fulciniti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Malvestiti S; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Prabhala RH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Talluri S; Department of Pediatric Hematology and Oncology, Freiburg University Hospital, Freiburg, Germany.
  • Wen K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Tai YT; VA Boston Healthcare System, Boston, Massachusetts.
  • Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Chauhan D; VA Boston Healthcare System, Boston, Massachusetts.
  • Sewastianik T; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Carrasco RD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Blood Cancer Discov ; 2(5): 468-483, 2021 09.
Article em En | MEDLINE | ID: mdl-34568832
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article